Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 15 of 15 Results
All Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Azilect® In Wearing-Off
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 18 Years and older
- Interventions:
- Drug: Azilectֲ®
Bradykinesia Subscale Administered Alone Versus Regular Administration
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 30 Years and older
- Interventions:
- Other: Bradykinesia UPDRS Motor Full Examination | Other: Bradykinesia subscale of UPDRS Motor Examination
Effect of Rasagiline in Patients With Parkinson's Disease
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 45 Years to 80 Years
- Interventions:
- Drug: Rasagiline | Drug: Placebo
Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 30 Years and older
- Interventions:
- Drug: rasagiline mesylate |Drug: Rasagiline mesylate plus Mirapex | Drug: Rasagiline mesylate with Levodopa | Drug: Rasagiline mesylate with Requip
Effectiveness, Tolerability, Safety of Rasagiline in Early Parkinson's Disease Patients Without Levodopa
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 35 Years and older
- Interventions:
- Drug: Rasagiline Mesylate | Drug: placebo
Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- Child, Adult, Older Adult
- Interventions:
- Drug: rasagiline mesylate
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 30 Years and older
- Interventions:
- Drug: Rasagiline | Drug: Placebo
Rasagiline in Participants Treated With Levodopa/Carbidopa Therapy
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 30 Years and older
- Interventions:
- Drug: rasagiline mesylate | Drug: rasagiline mesylate 1.0 mg
Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 35 Years and older
- Interventions:
- Drug: rasagiline mesylate
Study for Rasagiline Effect on Sleep Trial in Parkinson's Disease
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- Child, Adult, Older Adult
- Interventions:
- Drug: Rasagiline mesylate
Study of Rasagiline in Parkinson's Disease Patients Using Levodopa
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 30 Years and older
- Interventions:
- Drug: rasagiline mesylate | Drug: 1.0 mg rasagiline mesylate | Other: Placebo
Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 20 Years to 50 Years
- Interventions:
- Drug: Rasagiline | Drug: Placebo
Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- Child, Adult, Older Adult
- Interventions:
- Drug: rasagiline mesylate | Other: tyramine
Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 30 Years and older
- Interventions:
- Drug: rasagiline mesylate
Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 30 Years to 80 Years
- Interventions:
- Drug: Rasagiline Mesylate | Other: Placebo